Proximus NV (PROX)
Euronext Brussels · Belgium · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 5.495 |
|---|---|
| 52-week range | 5.460 – 8.545 |
| Return, 1 month / 3 months | −9.8% / −9.8% |
| Return, 1 year / 3 years | −21.9% / −1.8% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 29.6% |
| Worst drawdown (1 year) | -32.2% |
| Average daily value traded | 1.74M EUR |
| Dividend yield | 10.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Proximus is a telecommunications company based in Brussels, Belgium. It provides fixed-line and mobile telephony, broadband internet and television services to households and business customers, mainly in its home market. The company also offers information technology and network services to enterprises and public organisations. It operates under the Proximus brand, having previously been known as Belgacom, and serves customers across Belgium through its own networks and retail channels.
The shares are listed on the Euronext Brussels in Belgium under the code PROX, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Proximus NV (PROX) trades on the Euronext Brussels in Belgium. It last closed at EUR 5.495 on 23 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 72 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 21.9% and over the last three months it fell 9.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 25 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.3% | ||
| From 52-week high | -35.1% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.8% | ||
| 6-month return | -17.1% | ||
| 12-month return, skipping the last month | -13.4% | ||
| Stability (higher is calmer) | 41 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.2% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 1.74M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 96 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 10.9% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −8.4% |
|---|---|
| 1 month | −9.8% |
| 3 months | −9.8% |
| 6 months | −17.1% |
| 1 year | −21.9% |
| 3 years | −1.8% |
| 5 years | −45.4% |
Signals
| 50-day / 200-day average | 6.094 / 6.562 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.146 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Apr 2026 | EUR 0.3000 |
| 3 Dec 2025 | EUR 0.3000 |
| 23 Apr 2025 | EUR 0.1000 |
| 4 Dec 2024 | EUR 0.5000 |
| 24 Apr 2024 | EUR 0.7000 |
| 6 Dec 2023 | EUR 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.